Public Release: 

Elsevier partners with Tissue Viability Society

Journal of Tissue Viability expands reach

Elsevier

London, 29 August 2007 - Elsevier, a world-leading publisher of scientific, technical and medical information products and services is pleased to announce the formation of a publishing partnership with the Tissue Viability Society, an organization representing more than 1000 wound care specialists in the UK.

Under the agreement, Elsevier will assume publication of Journal of Tissue Viability, official journal of the Tissue Viability Society (http://www.tvs.org.uk/) from January 2008.

Journal of Tissue Viability is concerned with all aspects of the occurrence and treatment of wounds, ulcers and pressure sores including patient care, pain, nutrition, wound healing, research, prevention, mobility, social problems and management. The journal's audience includes various professions involved in tissue viability; primarily nurses but with many doctors, engineers, scientists, pharmacists, podiatrists and other professions also represented.

Dr Mike Clark, Editor, said "The Tissue Viability Society is excited by the agreement with Elsevier to publish the Journal of Tissue Viability. This will enable the Journal of Tissue Viability to reach a wider audience of wound healing professionals world-wide so strengthening the reputation of the Journal. The journal content will be printed at a faster pace and will also be accessible electronically together with other Elsevier journals. In addition, the submission and the reviewing of all manuscripts will be web-based, supported by Elsevier. This new procedure, which will be implemented shortly, will drastically reduce the reviewing process time and will be more cost-effective for the Journal."

Members of the Tissue Viability will continue to receive the print edition of Journal of Tissue Viability as a benefit of membership. In addition, members will be able to access the entire contents of each issue online. Other online features will include a comprehensive search engine, allowing users to search JTV alone, or to include hundreds of other Elsevier journals in a single query; options to sign up for e-mail alerts; and more. The Journal will be accessible through Elsevier's online database, ScienceDirect, the world's largest electronic collection of science, technology and medicine full text and bibliographic information.

###

About Tissue Viability Society
Formed in 1981 and a UK registered charity since 1996 the Society attracts members from all health care professions involved with tissue viability. The TVS mission statement:-'to disseminate information, promote research and increase awareness of all aspects of good clinical practice in wound prevention and management'.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.